Medicus Pharma Ltd.
MDCXNasdaqCIK 1997296HealthcareFiscal year ends Dec 31
Reports and events: 61 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-03-2816:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001062993-25-006485 |
| 2025-03-2520:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-006170 |
| 2025-03-2013:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-005954 |
| 2025-03-1116:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-005105 |
| 2025-02-1110:38 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-002033 |
| 2024-12-2608:00 ET | 6-K | Report of a foreign private issuerPeriod 2024-12-23 | 0001062993-24-021193 |
| 2024-12-1208:16 ET | 6-K | Report of a foreign private issuerPeriod 2024-12-12 | 0001062993-24-020512 |
| 2024-12-0210:00 ET | 6-K | Report of a foreign private issuerPeriod 2024-12-02 | 0001062993-24-019855 |
| 2024-11-2508:00 ET | 6-K | Report of a foreign private issuerPeriod 2024-09-30 | 0001062993-24-019596 |
| 2024-11-1817:00 ET | 6-K | Report of a foreign private issuerPeriod 2024-11-13 | 0001062993-24-019277 |
| 2024-11-1818:40 ET | 6-K | Report of a foreign private issuerPeriod 2024-11-13 | 0001062993-24-019231 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 04:09 ET. Listed shows no prices and gives no investment advice.